PharmaPatents Timely Insight on Emerging Legal Developments

Tag Archives: Bristol Meyers Squibb

District Court Stands By Patent Term Adjustment Tolling Decision

Posted by Courtenay Brinckerhoff on Posted in Patent Term Extension

In a decision issued September 20, 2012, in Bristol Meyers Squibb Co. v. Kappos, the U.S. District Court for the District of Columbia denied the USPTO’s motion for reconsideration of the court’s January 27, 2012 decision that found that the statutory deadline for bringing a civil action to challenge the Patent Term Adjustment (PTA) awarded by the USPTO is tolled when the patentee pursues reconsideration of the agency decision. This ruling is significant, because the 180-day statutory period often occurs before the USPTO issues its decision on a request for reconsideration.Continue reading this entry

USPTO Requests Reconsideration In Patent Term Adjustment Tolling Case

Posted by Courtenay Brinckerhoff on Posted in Patent Term Adjustment

The USPTO has filed a motion requesting reconsideration in Bristol Meyers Squibb Co. v. Kappos, where the U.S. District Court for the District of Columbia found that the statutory deadline for bringing a civil action to challenge the Patent Term Adjustment (PTA) awarded by the USPTO is tolled when the patentee pursues reconsideration of the agency decision. As I wrote previously, the court’s original ruling was significant, because the 180-day statutory period often runs before the USPTO has issued its final decision. If the deadline is not tolled, a patentee must decide whether to bring a civil action to contest a PTA award even before the USPTO has made it’s final PTA calculation. Continue reading this entry

District Court Finds That Deadline To File PTA Action Was Tolled By Request For Reconsideration

Posted by Courtenay Brinckerhoff on Posted in Patent Term Adjustment

In a decision issued January 27, 2012, in Bristol Meyers Squibb Co. v. Kappos, the U.S. District Court for the District of Columbia found that the statutory deadline for bringing a civil action to challenge the Patent Term Adjustment (PTA) awarded by the USPTO is tolled when the patentee pursues reconsideration of the agency decision. This ruling is significant, because the 180-day statutory period often occurs before the USPTO issues its final decision on a request for reconsideration. Continue reading this entry